Apollo Endosurgery (APEN) Stock Highlights

10 | +0%

2023-05-04 17:59:30

Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focuses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The companys products include the OverStitch Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System, and the Orbera Intragastric Balloon System.

Statistics

Range Today

10 10

Volume Today 0

Range 1 Year

3.49 10.3

Volume 1 Year 166.9M

Range 3 Year

1.25 10.39

Volume 3 Year 284.58M

Range 10 Year

1.24 515.9

Volume 10 Year 336.82M

Highlights

Market Capitalization 579.72M (small)

Floating Shares 39.54M

Current Price 10

Price To Earnings -9.37

Price To Revenue 7.54

Price To Book 12.89

Earnings Per Share -1.06

Payout Ratio 0%

Performance

Latest 0%

1 Month +0.91%

3 Months +1.11%

6 Months +103.25%

1 Year +73.61%

3 Years +318.41%

5 Years +67.5%

10 Years -97.43%

Benchmarks

Market Capitalization

44 / 92

Gross Profits

54 / 85

Total Revenue

56 / 89

Total Rank

47 / 92

Free Cashflow

64 / 90

Performance 5 years

16 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.